475 related articles for article (PubMed ID: 16242524)
1. Levosimendan improves postresuscitation outcomes in a rat model of CPR.
Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W
J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524
[TBL] [Abstract][Full Text] [Related]
2. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
Huang L; Weil MH; Tang W; Sun S; Wang J
Crit Care Med; 2005 Mar; 33(3):487-91. PubMed ID: 15753736
[TBL] [Abstract][Full Text] [Related]
3. Combination pharmacotherapy in the treatment of experimental cardiac arrest.
Xanthos T; Bassiakou E; Koudouna E; Rokas G; Goulas S; Dontas I; Kouskouni E; Perrea D; Papadimitriou L
Am J Emerg Med; 2009 Jul; 27(6):651-9. PubMed ID: 19751621
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest.
Koudouna E; Xanthos T; Bassiakou E; Goulas S; Lelovas P; Papadimitriou D; Tsirikos N; Papadimitriou L
Acta Anaesthesiol Scand; 2007 Sep; 51(8):1123-9. PubMed ID: 17697310
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan improves postresuscitation myocardial dysfunction after beta-adrenergic blockade.
Wang J; Weil MH; Tang W; Sun S; Huang L
J Lab Clin Med; 2005 Sep; 146(3):179-83. PubMed ID: 16131457
[TBL] [Abstract][Full Text] [Related]
6. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Leppikangas H; Ruokonen E; Rutanen J; Kiviniemi V; Lindgren L; Kurola J
Ann Emerg Med; 2009 Dec; 54(6):811-817.e1-3. PubMed ID: 19766354
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
[TBL] [Abstract][Full Text] [Related]
10. Mechanism by which activation of delta-opioid receptor reduces the severity of postresuscitation myocardial dysfunction.
Fang X; Tang W; Sun S; Huang L; Huang Z; Weil MH
Crit Care Med; 2006 Oct; 34(10):2607-12. PubMed ID: 16775573
[TBL] [Abstract][Full Text] [Related]
11. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
Sonntag S; Sundberg S; Lehtonen LA; Kleber FX
J Am Coll Cardiol; 2004 Jun; 43(12):2177-82. PubMed ID: 15193677
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan compared with dobutamine in low output patients.
Nieminen MS
Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717
[TBL] [Abstract][Full Text] [Related]
13. Influence of dobutamine on the variables of systemic haemodynamics, metabolism, and intestinal perfusion after cardiopulmonary resuscitation in the rat.
Studer W; Wu X; Siegemund M; Marsch S; Seeberger M; Filipovic M
Resuscitation; 2005 Feb; 64(2):227-32. PubMed ID: 15680534
[TBL] [Abstract][Full Text] [Related]
14. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
Kerbaul F; Rondelet B; Demester JP; Fesler P; Huez S; Naeije R; Brimioulle S
Crit Care Med; 2006 Nov; 34(11):2814-9. PubMed ID: 16971854
[TBL] [Abstract][Full Text] [Related]
15. Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity.
Graudins A; Najafi J; Rur-SC MP
Clin Toxicol (Phila); 2008 Jan; 46(1):50-6. PubMed ID: 17926153
[TBL] [Abstract][Full Text] [Related]
16. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
18. Improved outcomes of cardiopulmonary resuscitation in rats with myocardial infarction treated with allogenic bone marrow mesenchymal stem cells.
Wang T; Tang W; Sun S; Ristagno G; Xu T; Weil MH
Crit Care Med; 2009 Mar; 37(3):833-9. PubMed ID: 19237885
[TBL] [Abstract][Full Text] [Related]
19. Minimal interruption of cardiopulmonary resuscitation for a single shock as mandated by automated external defibrillations does not compromise outcomes in a porcine model of cardiac arrest and resuscitation.
Ristagno G; Tang W; Russell JK; Jorgenson D; Wang H; Sun S; Weil MH
Crit Care Med; 2008 Nov; 36(11):3048-53. PubMed ID: 18824916
[TBL] [Abstract][Full Text] [Related]
20. Evidence favoring the use of an alpha2-selective vasopressor agent for cardiopulmonary resuscitation.
Pellis T; Weil MH; Tang W; Sun S; Xie J; Song L; Checchia P
Circulation; 2003 Nov; 108(21):2716-21. PubMed ID: 14623815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
